SCHEMBL7059581

SCHEMBL7059581

CCCCCCCCCCCCc1ccccc1C(C)C

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 9/20 0.55
CYSLTR1 Q9Y271 9/20 0.55
LIPG Q9Y5X9 1/20 0.55
NR1H2 P55055 1/20 0.45
NR1H3 Q13133 1/20 0.45
SOAT1 P35610 1/20 0.44
BID P55957 3/20 0.42
MCL1 Q07820 3/20 0.42
BCL2L1 Q07817 2/20 0.42
BAK1 Q16611 2/20 0.42
KAT8 Q9H7Z6 2/20 0.42
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
EP300 Q09472 1/20 0.42
KAT2A Q92830 1/20 0.42
KAT2B Q92831 1/20 0.42
KAT5 Q92993 1/20 0.42
SAE1 Q9UBE0 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9136145 1.00 CYSLTR2 (0.55) CYSLTR2CYSLTR1LIPGNR1H2NR1H3
SCHEMBL17439641 1.00 CYSLTR2 (0.55) CYSLTR2CYSLTR1LIPGNR1H2NR1H3
SCHEMBL3267051 1.00 CYSLTR2 (0.55) CYSLTR2CYSLTR1LIPGNR1H2NR1H3
SCHEMBL28775644 1.00 CYSLTR2 (0.55) CYSLTR2CYSLTR1LIPGNR1H2NR1H3
SCHEMBL9135788 1.00 CYSLTR2 (0.55) CYSLTR2CYSLTR1LIPGNR1H2NR1H3
SCHEMBL28501684 1.00 CYSLTR2 (0.55) CYSLTR2CYSLTR1LIPGNR1H2NR1H3
Hydrogen Sulfide SCHEMBL28224981 0.98 CYSLTR2 (0.54) CYSLTR2CYSLTR1LIPGNR1H2NR1H3
SCHEMBL8091006 0.98 CYSLTR2 (0.53) CYSLTR2CYSLTR1LIPGNR1H2NR1H3
Hydrogen Peroxide SCHEMBL11209358 0.96 CYSLTR2 (0.60) CYSLTR2CYSLTR1LIPGBIDMCL1
SCHEMBL30436245 0.92 CYSLTR2 (0.46) CYSLTR2CYSLTR1LIPGSOAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019121810-A1 PIPELINE CLEANING COMPOSITION PIPE MAINTENANCE INTERNATIONAL LTD. (GB) 2019-06-27 WO disclosed
EP-3063128-B1 PROCESS FOR PREPARING A PARA-LINEAR ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOUND CHEVRON ORONITE CO (US) 2018-10-24 EP disclosed
CN-108570204-A Polypropylene resin composite and its shaped article 现代自动车株式会社 2018-09-25 CN disclosed
EP-3063128-A1 PROCESS FOR PREPARING A PARA-LINEAR ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOUND Chevron Oronite Company LLC (US) 2016-09-07 EP disclosed
US-9376359-B2 Process for preparing a para-linear alkyl-substituted hydroxyaromatic compound CHEVRON ORONITE COMPANY LLC (US) 2016-06-28 US disclosed
WO-2015065528-A1 PROCESS FOR PREPARING A PARA-LINEAR ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOUND CHEVRON ORONITE COMPANY LLC (US) 2015-05-07 WO disclosed
US-20150119308-A1 PROCESS FOR PREPARING A PARA-LINEAR ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOUND CHEVRON ORONITE COMPANY LLC (US) 2015-04-30 US disclosed
EP-0910619-B1 CLEANING METHOD FOR TEXTILE FABRICS PROCTER & GAMBLE (US) 2003-05-28 EP disclosed
US-4666500-A HERBICIDE MONSANTO COMPANY (US) 1987-05-19 US disclosed
US-4395374-A HERBICIDES, PLANT GROWTH REGULATORS MONSANTO COMPANY (US) 1983-07-26 US disclosed
US-4323387-A N-Thiolcarbonyl derivatives of N-phosphonomethylglycinonitrile esters, herbicidal compositions and use thereof MONSANTO COMPANY (US) 1982-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150119308-A1 PROCESS FOR PREPARING A PARA-LINEAR ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOUND CYP1A1, CYP2E1, POR CYSLTR2 2236/4885CYSLTR1 2381/4885LIPG 1816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.